Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Emergence of fluoroquinolone resistance in Bacteroides fragilis accompanied by resistance to beta-lactam antibiotics.

Literature DB >> 2848446

Emergence of fluoroquinolone resistance in Bacteroides fragilis accompanied by resistance to beta-lactam antibiotics.

N Kato¹, M Miyauchi, Y Muto, K Watanabe, K Ueno.

Abstract

The in vitro susceptibilities of a group of 93 isolates of Bacteroides fragilis collected from 1983 to 1984 to six fluoroquinolones were compared with those of a group of 93 isolates collected from 1986 to 1987. The recently collected strains were less susceptible than the older strains to all of the agents tested. Norfloxacin-resistant (MIC, greater than 100 micrograms/ml) strains were less susceptible to cefoxitin and piperacillin than norfloxacin-susceptible strains.

Entities: Chemical Species

Mesh：

Substances：

Year: 1988 PMID： 2848446 PMCID： PMC175885 DOI： 10.1128/AAC.32.9.1437

Source DB: PubMed Journal: Antimicrob Agents Chemother ISSN： 0066-4804 Impact factor: 5.191

12 in total

1. Ciprofloxacin-resistant Pseudomonas.

Authors: C M Roberts; J Batten; M E Hodson
Journal: Lancet Date: 1985-06-22 Impact factor: 79.321

2. Clinical resistance to long-term oral ciprofloxacin.

Authors: S M Crook; J B Selkon; P D McLardy Smith
Journal: Lancet Date: 1985-06-01 Impact factor: 79.321

3. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.

Authors: D C Hooper; J S Wolfson; K S Souza; C Tung; G L McHugh; M N Swartz
Journal: Antimicrob Agents Chemother Date: 1986-04 Impact factor: 5.191

4. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

Authors: K Fujimaki; T Noumi; I Saikawa; M Inoue; S Mitsuhashi
Journal: Antimicrob Agents Chemother Date: 1988-06 Impact factor: 5.191

5. In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.

Authors: S Nakamura; A Minami; H Katae; S Inoue; J Yamagishi; Y Takase; M Shimizu
Journal: Antimicrob Agents Chemother Date: 1983-05 Impact factor: 5.191

6. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

Authors: N X Chin; H C Neu
Journal: Antimicrob Agents Chemother Date: 1984-03 Impact factor: 5.191

7. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

Authors: C C Sanders; W E Sanders; R V Goering; V Werner
Journal: Antimicrob Agents Chemother Date: 1984-12 Impact factor: 5.191

Emergence of fluoroquinolone resistance in Bacteroides fragilis accompanied by resistance to beta-lactam antibiotics.

1. Ciprofloxacin-resistant Pseudomonas.

2. Clinical resistance to long-term oral ciprofloxacin.

3. Genetic and biochemical characterization of norfloxacin resistance in Escherichia coli.

4. In vitro and in vivo antibacterial activities of T-3262, a new fluoroquinolone.

5. In vitro antibacterial properties of AT-2266, a new pyridonecarboxylic acid.

6. Ciprofloxacin, a quinolone carboxylic acid compound active against aerobic and anaerobic bacteria.

7. Selection of multiple antibiotic resistance by quinolones, beta-lactams, and aminoglycosides with special reference to cross-resistance between unrelated drug classes.

8. In vitro and in vivo activity of DL-8280, a new oxazine derivative.

9. In vitro activity of ciprofloxacin (Bay o 9867).

10. In vitro activity of Bay 09867, a new quinoline derivative, compared with those of other antimicrobial agents.

1. Survey of the susceptibility patterns of Bacteroides fragilis group strains in France from 1977 to 1992.

Review 2. Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

3. In vitro susceptibility of clinical isolates of Bacteroides fragilis and Bacteroides thetaiotaomicron in Japan.